Literature DB >> 24637973

Insomnia: psychological and neurobiological aspects and non-pharmacological treatments.

Yara Fleury Molen, Luciane Bizari Coin Carvalho, Lucila Bizari Fernandes do Prado, Gilmar Fernandes do Prado.   

Abstract

Insomnia involves difficulty in falling asleep, maintaining sleep or having refreshing sleep. This review gathers the existing informations seeking to explain insomnia, including those that focus on psychological aspects and those considered neurobiological. Insomnia has been defined in psychological (cognitive components, such as worries and rumination, and behavioral aspects, such as classic conditioning) and physiological terms (increased metabolic rate, with increased muscle tone, heart rate and temperature). From the neurobiological point of view, there are two perspectives: one which proposes that insomnia occurs in association with a failure to inhibit wakefulness and another that considers hyperarousal as having an important role in the physiology of sleep. The non-pharmacological interventions developed to face different aspects of insomnia are presented.

Entities:  

Mesh:

Year:  2014        PMID: 24637973     DOI: 10.1590/0004-282X20130184

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  3 in total

1.  Are Morbid Obesity and Insomnia Related? Investigating Associated Factors in a Clinical Setting.

Authors:  Mariëtte van Buuren; Chris Hinnen
Journal:  J Clin Psychol Med Settings       Date:  2020-03

2.  A Randomized Controlled Trial Comparing Neurofeedback and Cognitive-Behavioral Therapy for Insomnia Patients: Pilot Study.

Authors:  Yunna Kwan; Soyoung Yoon; Sooyeon Suh; Sungwon Choi
Journal:  Appl Psychophysiol Biofeedback       Date:  2022-02-11

3.  Cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis: protocol for the randomised, single-blinded, parallel-group Sleep-RA trial.

Authors:  K M Latocha; K B Løppenthin; M Østergaard; P J Jennum; R Christensen; M Hetland; H Røgind; T Lundbak; J Midtgaard; B A Esbensen
Journal:  Trials       Date:  2020-05-29       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.